CR
CRLBF.US Cresco Labs Inc
- Market cap
- USD 189M
- P/E
- -
- P/B
- 0.51x
- ROE
- -3.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is CRLBF.US undervalued?
Graham numberThe Graham number of Cresco Labs Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Cresco Labs Inc fundamental analysis
No fundamental analysis for Cresco Labs Inc yet.
Cresco Labs Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Cresco Labs Inc
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes, gummies, and pre-rolls under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, cap…
Full company profileCresco Labs Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Cresco Labs Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 0.00 | 0.00 | 43.3M | 129M | 476M | 822M | 843M | 771M | 724M | 656M | 663M |
| Gross Profit | -4.16M | 1.15M | 40.4M | 64.1M | 284M | 406M | 407M | 362M | 364M | 325M | 323M |
| Operating Income | -42.9K | -44.4K | 6.60M | -34.3M | 55.8M | 87.8M | 56.9M | 62.9M | 109M | 76.9M | 46.9M |
| EBITDA | - | -43.8K | 8.77M | -29.5M | 88.1M | -160M | -10.7M | -14.0M | 113M | 20.3M | 84.7M |
| Net Income | -108K | -85.4K | -1.92M | -43.2M | -81.9M | -320M | -212M | -176M | -74.4M | -135M | -11.6M |
| EPS | - | -2.45 | -0.02 | -0.33 | -0.37 | -1.17 | -0.70 | -0.52 | -0.21 | -0.38 | -0.03 |
| Balance Sheet | |||||||||||
| Total Assets | 75.7K | 1.84K | 318M | 617M | 1.33B | 1.78B | 1.58B | 1.36B | 1.36B | 1.20B | 1.25B |
| Total Liabilities | 997K | 1.07M | 35.1M | 294M | 608M | 983M | 996M | 930M | 967M | 945M | 1.00B |
| Shareholders' Equity | -921K | -1.06M | 283M | 323M | 725M | 798M | 588M | 428M | 388M | 253M | 350M |
| Cash & Short-term Investments | 0.00 | 0.00 | 131M | 49.1M | 136M | 224M | 119M | 103M | 138M | 57.9M | 41.2M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -10.6M | -4.90M | -9.92M | -25.2M | -7.85M | 14.5M | 18.7M | 58.6M | 132M | 72.9M | - |
| Capital Expenditure | 103K | 4.06M | 29.2M | 91.7M | 87.2M | 93.9M | 86.1M | 57.9M | 23.5M | 38.2M | 27.9M |
| Free Cash Flow | - | 29.9K | -39.9M | -121M | -91.2M | -82.6M | -67.4M | 681K | 109M | 34.7M | - |
| Ratios | |||||||||||
| ROE | - | - | -0.7% | -13.4% | -11.3% | -40.1% | -36.1% | -41.0% | -19.2% | -53.6% | -3.3% |
| ROA | -142.6% | -4,643.0% | -0.6% | -7.0% | -6.1% | -18.0% | -13.4% | -12.9% | -5.5% | -11.3% | -0.9% |
| Net Profit Margin | - | - | -4.4% | -33.6% | -17.2% | -38.9% | -25.2% | -22.8% | -10.3% | -20.6% | -1.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Cresco Labs Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | USD 162K | 0.00 | - |
| 2019 | USD 2.94M | 0.02 | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:812 on Dec 3, 2018.
Who owns Cresco Labs Inc
- Insiders 2.21%
- Institutions 5.06%
- Public & others 92.74%
- Shares outstanding 361M
- Free float 345M
Cresco Labs Inc company profile
- Company name
- Cresco Labs Inc
- Ticker
- CRLBF.US
- ISIN
- CA22587M1068
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 2,900
- Fiscal year end
- December
- Address
- 600 W. Fulton Street, Chicago, IL, United States, 60661
- Phone
- 312 929 0993
- Website
- crescolabs.com
About Cresco Labs Inc
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes, gummies, and pre-rolls under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers cannabis flowers under the FloraCal brand; and cannabis oils and variety of bites are available at multiple potency levels under the Mindy's brand, as well as Loud*r brand. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company is headquartered in Chicago, Illinois.
Cresco Labs Inc management
10- Mr. Charles BachtellCo-Founder, CEO & Director · born 1979
- Mr. Gregory ButlerPresident · born 1980
- Mr. Robert M. SampsonCo-Founder & Independent Director · born 1975
- Mark StortzSenior VP, Corporate Controller & Interim CFO
- Mr. Ty GentChief Operating Officer · born 1959
- Mr. Zach MarburgerChief Information Officer · born 1985
- T.J. ColeSenior Vice President of Corporate Development and Investor Relations
- Ms. Angie DemchenkoChief People Officer · born 1981
- Mr. Joseph AlesSenior VP of Operations
- Mr. Drew DuvalSenior Vice President of Cultivation